Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Speaker: Peter Campbell – The Wellcome Trust Sanger Inst
Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
Speaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels
Speaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA
Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland
Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami
Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University
Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
Speaker: Leif Bergsagel, MD – Mayo Clinic Arizona
Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University
Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona
Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic
Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center
Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK
Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
Speaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital
Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center
Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE
Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil
Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy
Panelist: Bindu Kanapuru
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
Speaker: Siddhartha Mukherjee
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele
Speaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam
Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration
Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA
Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University
Speaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra
Speaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA
Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig
Speaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute
Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
Panelist: Sonja Zweegman, MD, PhD – Amsterdam UMC
Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole
Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester
Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary
Speaker: Lawrence Boise, PhD (he/him/his) – Emory University
Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University
Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra
Speaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute
Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg
Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital
Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network
Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre
Panelist: Ajai Chari, MD, PhD – University of California, San Francisco
Panelist: Bindu Kanapuru
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
Speaker: Flavia Pichiorri, PhD (she/her/hers) – City of Hope
Speaker: Marc-A. Baertsch, MD – German Cancer Research Center (DKFZ)
Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra
Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
Speaker: Adam D Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA
Speaker: Joshua Richter, MD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Speaker: Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China
Speaker: Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA
Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
Speaker: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute
Panelist: Ivan Borrello, MD – Tampa General Hospital
Panelist: Tom Martin, MD (he/him/his) – UCSF
Panelist: Monika Engelhardt
Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center
Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens
Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens
Speaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute
Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine
Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US
Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital
Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic
Speaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece
Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School
Speaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino
Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore
Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA
Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada
Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC
Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France